Paricalcitol Impurity 8 is a pharmaceutical impurity reference standard, specifically a stereochemically defined intermediate related to paricalcitol. It is characterized as a diol with three alcohol groups and a ring-containing structure, used primarily in quality control and analytical testing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Paricalcitol Impurity 8?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
1,25-dihydroxycalciferol
pharmaceutical raw material
Ethanol, 2-[(4-amino-5-methoxy-2-methylphenyl)sulfonyl]-, hydrogen sulfate (ester)
pharmaceutical intermediate
6-(Trifluoromethyl)nicotinonitrile
pharmaceutical intermediate
Cis-2,6-Dimethylpiperazine
pharmaceutical intermediate
1,3-Adamantanediol monoacrylate
pharmaceutical intermediate
Paricalcitol
pharmaceutical raw material
Paricalcitol Impurity 2
pharmaceutical intermediate
22Z-Paricalcitol
research compound
cis-(1R,3S)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
BPKAHTKRCLCHEA-DMCZTGDPSA-N
C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C3C[C@@H](C[C@@H](C3)O)O)C
Sourcing Paricalcitol Impurity 8?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.